Use of Alendronate Sodium (Fosamax) to Ameliorate Osteoporosis in Renal Transplant Patients: A Case-Control Study

PLoS ONE - United States
doi 10.1371/journal.pone.0048481
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Enteric-Coated Mycophenolate Sodium Can Be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2004English

Effect of Co-Administration of Alendronate and Allan Sodium Phosphate for the Management of Osteoporosis

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2019English

A Comparative Study Between Intravenous and Oral Alendronate Administration for the Treatment of Osteoporosis

SpringerPlus
Multidisciplinary
2015English

Fungal Infections in Renal Transplant Patients

Journal of Clinical Medicine Research
2015English

Paravertebral Catheter Use for Postoperative Pain Control in Patients After Lung Transplant Surgery: A Prospective Observational Study

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
2017English

Occurrence of Osteoporosis in COPD Patients- A Comparative Study With Age & Sex Matched Control

journal of medical science and clinical research
2017English

Study of the Risk Factors Related to Acquisition of Urinary Tract Infections in Patients Submitted to Renal Transplant

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2015English

Renal Involvement in Epidermolysis Bullosa Patients: A Case Series Study

Journal of Pediatrics & Neonatal Care
2018English

Cyclosporin-Erythromycin Interaction in Renal Transplant Patients.

British Journal of Clinical Pharmacology
Pharmacology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy